Clinical trials, cited in the New England Journal of Medicine , show that out of 2,000 participants who did weekly semaglutide injections, most lost at least 10% of their body weight, and more than half lost 15% of their body weight
Patients should be educated on hypersensitivity symptoms, such as hives or chest tightness, so they can access care promptly if symptoms occur
For women with PCOS or insulin resistance, GLP-1s may help restore ovulation
Check out this blog on 9 GLP Meal Ideas for some inspiration about what to eat throughout the day
Tirzepatide: Tirzepatide, a dual GIP/GLP-1 agonist, represents a newer generation of metabolic peptides with potent weight loss effects through combined appetite suppression and metabolic enhancement
These are averages, meaning some individuals exceed them substantially